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Introduction
Multiple myeloma (MM) is an incurable neoplasm of terminally-differentiated B cells that is characterized by monoclonal expansion of malignant plasma cells. The common premalignant stage of MM is a monoclonal gammopathy of undetermined significance (MGUS), which progresses to MM at the rate of 1% of patients per year (1) . Extensive genomic analysis has revealed that approximately 50% of patients with MGUS and MM have primary translocations in the clonal plasma cells that involve the immunoglobulin heavy chain (IGH) locus on chromosome 14q32 (2) . Chromosomal translocations that involve the juxtaposition of the IGH locus with the loci for CYCLIN D1 (3), FGFR3 (4), or MMSET (5) result in the overexpression of these genes. It was first reported a decade ago that c-MAF is expressed at high levels in MM cells that carry the translocation t(14;16)(q32;q23), in which the IGH locus is fused with the c-MAF gene locus (6) . In addition, c-MAF is overexpressed in 50% of MM cell lines and patients (7) .
The maf proto-oncogene was identified originally within the genome of the avian musculoaponeurotic fibrosarcoma virus, AS42 (8) . The product of the Maf gene and other members of the Maf family share a conserved basic-region leucine zipper (bZIP) motif that mediates dimer formation and DNA binding to the Maf recognition element (MARE) (9) . Large Maf proteins, such as c-Maf, Mafb, Mafa/L-Maf/SMaf and Nrl, also contain an acidic domain that mediates transcriptional activation and plays a 4 key role in cellular differentiation (8) (9) (10) (11) (12) . c-Maf encodes a T helper cell type 2 (Th2)-specific transcription factor that activates the expression of interleukin (IL)-4 in T cells (13) . c-Maf is also involved in the regulation of lens fiber cell differentiation (14) (15) (16) . Recently, we have found that transgenic mice that express c-Maf specifically in the T-cell compartment develop T-cell lymphoma (17) . Furthermore, 60% of human T-cell lymphomas, classified as angioimmunoblastic T-cell lymphomas, were found to overexpress c-MAF (17, 18) .
On the basis of the above facts, we hypothesized that overexpression of c-Maf in the B cell lineage would enhance the development of an MM-like disease. In this study, we have generated c-Maf transgenic mice that overexpress c-Maf in the B-cell compartment, using the IgH promoter and Eμ enhancer. We found that these mice developed B cell lymphoma, which provided the first direct evidence that c-Maf can function as an oncogene in a murine model of the t(14;16)(q32;q23) translocation.
Materials and Methods
Mice. We made two constructs for the Eμ c-Maf transgene (Fig. 1A) . For construct-1, we used the Eμ enhancer and the V H promoter, as described previously (19) . A 1.5-kb full-length cDNA that encoded the murine c-Maf protein was inserted into a vector that contained the V H promoter and Eμ enhancer. Construct-1 was injected into fertilized eggs from BDF1 mice to generate transgenic mice, and then backcrossed four times into C57BL/6J. For construct-2, the V H promoter, Eμ enhancer, and 3'Eκ enhancer were used. Construct-2 was injected into fertilized eggs from C57BL/6J mice to generate transgenic mice. Mice were maintained with a C57BL/6J genetic background in specific pathogen-free conditions in a Laboratory Animal Resource Center. All experiments were carried out according to the Guide for the Care and Use of Laboratory Animals at the University of Tsukuba.
Southern hybridization analysis. High molecular weight DNA was prepared from the tail of each mouse, and 10 μg of this DNA was digested with EcoR I and Hind III, and then Southern hybridization was performed, as described previously (17) . To investigate IgH gene rearrangement, DNA from the tail and other tissues was examined by Southern hybridization. DNA that had been digested with EcoR I was hybridized with the JH4 fragment, as described previously (20) . 
Isolation of mouse

Statistical analysis.
Results were expressed as the mean ± SE. Data were compared by one-way analysis of variance (ANOVA) and the Bonferroni correction was applied routinely. Significant differences between the groups of mice were analyzed using the Wilcoxon test for paired samples, and values of p<0.05 were considered statistically significant. Survival rates were compared using the Kaplan-Meier method. 1A ). We generated two constructs (the first did not contain the 3' Eκ enhancer) and obtained 17 F0 transgenic mice with a BDF1 or C57BL/6J genetic background.
Results
Generation of Eμ c-
Subsequently, three transgenic mouse lines with a C57BL/6J genetic background were generated, and screened by PCR using tail DNA as the template. that TG (transgenic) line 524, which was generated using construct-1, contained approximately four copies of the transgene, whereas TG lines 99 and 68, which were generated with construct-2, both contained approximately two copies (Fig. 1B, a) .
These transgenes were stably transmitted to the progeny.
Overexpression of c-Maf in transgenic mice. To confirm that the transgene was expressed, the levels of c-Maf mRNA and protein in splenic B cells from the TG lines were monitored by RT-PCR and western blotting (Fig. 1B, b and c) . The c-Maf mRNA was overexpressed in all the transgenic mice that were tested (Fig. 1B, b) .
Correspondingly, western blot analysis of B220 + splenic B cells confirmed that the levels of c-Maf protein were elevated (Fig. 1B, c Fig. 2A) . We could not detect any apparent difference in survival between the mice that were generated with the two different constructs, construct-1 for TG524, and construct-2 for TG 99 and 68. (Fig. 2B) . Cells that had infiltrated demonstrated plasma cell-like morphology (Fig. 2B) . Moreover, immunohistochemical analysis revealed that the infiltrating cells were B220 + (Fig. 2C) , and also expressed CD138 (Fig. 2C) . We confirmed that the infiltrating cells were positive for both CD138 and c-Maf by immunofluorescence staining (Fig. 2C) . To investigate the characteristics of the lymphoma cells, we performed flow cytometry ( Fig. 2C and D) . We found the number of B220 + CD138 + CD21 + CD23 + IgM + IgD -cells was increased in the transgenic mice relative to the wild-type mice. We also found that the number of mature plasma cells (B220 low CD138 + ) was increased in the transgenic mice (Fig. 2C) . (Fig. 3B) . The mean amount of total IgG in the transgenic mice was 1760 ± 302 (mg/dl), whereas in the control mice this value was 934 ± 142 (mg/dl) (p<0.05). In addition, the mean amount of total IgM in the transgenic mice was 1083 ± 223 (mg/dl), whereas in the control mice this value was 564 ± 92 (mg/dl). However, there was no obvious elevation of total IgA in the transgenic mice. It must be noted that only one out of the 14 mice showed high levels of both IgG and IgM (Fig. 3B) . Notably, these changes in the serum were associated with increased numbers of mature plasma cells (B220 low CD138 + ) in the bone marrow;
Lymphomas observed in
Hypergammmaglobulinemia in aged Eμ
the proportion of plasma cells as a percentage of the total number of bone marrow cells was 5-20% in the transgenic mice compared to <5% in the non-transgenic controls (Fig. 3C) . We also found the number of B220 + CD138 + cells in the bone marrow was increased (Fig. 3C) . However, we could not identify any obvious osteolytic lesions by X-ray analysis (Fig. 3C) . analysis was carried out using a murine JH4 probe (Fig. 5B) . We extracted DNA from the tails, and spleens of the mice. Monoclonal rearrangement of the IgH locus was found in DNA that had been isolated from the spleens of the Eμ c-Maf transgenic mice (Fig. 5B, lanes 3 to 6) . Histological analysis of the spleen from these recipient mice revealed that the tumor cells showed a plasma cell-like morphology, i.e. the same as the original lymphoma cells (Fig. 5C ).
Expression of c-Maf target genes in Eμ c-Maf transgenic mice.
To gain insight into the molecular mechanism by which plasma cell dyscrasia develops, we measured the level of mRNA expression from c-Maf and its target genes in Eμ c-Maf transgenic mice using a quantitative RT-PCR assay (Fig. 6) . In human MM, CYCLIN D2 and INTEGRIN β7 are known to be targets of c-MAF (7, 23). As we described previously, deregulated expression of Cyclin D2 and Integrin β7 is also observed in the T cell lymphomas of transgenic mice that overexpress c-Maf in the T lymphoid compartment (17) . Therefore, we analyzed the expression of Cyclin D2 and Integrin β7 in Eμ c-Maf (Fig. 6) . We confirmed the percentage of B220 + cells in the lymph nodes was over 70 %. We also found that the expression of both Cyclin D2 and
Integrin β7 was elevated in Eμ c-Maf transgenic mice (Fig. 6) , which was consistent with the results of previous reports in human MM (7).
Next, we examined the levels of the B cell-associated transcription factors, Prdm1 (Blimp-1), Xbp1 and Pax5. Blimp-1 is a transcriptional repressor that plays a critical role in the terminal differentiation of B cells into antibody-secreting plasma cells (24) . Overexpression of Blimp-1 has been shown to drive plasma cell differentiation (24) (25) (26) . Xbp1 is a basic-region leucine zipper (bZIP) transcription factor and a major regulator of plasma cell differentiation (27) . It is known that Eμ Xbp1s mice develop MM/MGUS (28) . In addition, Pax5 is known to inhibit plasmacytic development, and also to repress the expression of Xbp1, which is needed for plasma cell formation and immunoglobulin secretion (29) . By RT-PCR analysis (Fig. 6) , we found that Prdm1 and Xbp1 expression were increased, but Pax5 expression was decreased, in the transgenic mice as compared to the control mice, which might correlate with the plasma cell differentiation.
It is known that the dysregulation of MYC (c-MYC) expression can induce the progression of MGUS to MM (1). In addition, it has been reported that myeloma cells are completely dependent on the transcription factor IRF4 (interferon regulatory factor 4), despite that fact that most myeloma cells do not harbour mutations, translocations or amplifications of the IRF4 locus (30) . Moreover, IRF4 is itself a direct target of MYC, which generates an autoregulatory circuit in myeloma cells (30) . However, neither
Myc nor Irf4 expression were elevated in the Eμ c-Maf transgenic mice. We also analyzed Spp1 (osteopontin) expression, because we could not find any obvious osteolytic lesions in the Eμ c-Maf transgenic mice. SPP1, which is highly expressed in MM, plays a critical role in bone disease by protecting the bone from destruction (31).
We observed that the expression of Spp1 was up-regulated in Eμ c-Maf transgenic mice (Fig. 6 ).
Discussion
It is important to emphasize that v-maf is a classical oncogene that was identified in an avian transforming virus, AS42 (8) . Large Maf proteins, such as c-Maf, Mafb and Mafa, can efficiently transform primary fibroblasts in vitro (9, (32) (33) (34) . Previously, we generated c-Maf transgenic mice that overexpress c-Maf in the T-cell compartment using the VA vector, which contains the human CD2 promoter and locus control region.
The Further studies will be needed to define the role of c-Maf in the development of both human and mouse MM. Clarification of the mechanism by which c-Maf contributes to oncogenesis may ultimately facilitate the discovery of more specific therapies to prevent the progression of MM.
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